← Eichor
Condition: Proliferative Glomerulonephritis With Monoclonal Igg Deposit Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Proliferative Glomerulonephritis With Monoclonal Igg Deposit

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits
Phase 2 · 4 location(s) · Mayo Clinic · NCT05654506
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.